---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-24-049979"
form_type: "8-K"
ticker: "AVTX"
cik: "0001534120"
company_name: "Avalo Therapeutics, Inc."
filed_at: "2024-12-05T23:59:59+00:00"
generated_at: "2026-05-29T07:14:39.956766+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# Avalo Therapeutics posts updated investor presentation; no material new details available

## Summary
- Avalo Therapeutics posted an updated investor presentation on its website on December 5, 2024.
- The presentation is intended for use in meetings with investors; no specific financial or operational updates disclosed in the filing.
- No earnings, guidance, or material events were reported; the filing is a routine business update.

## SEC filing metadata
- accession: 0001628280-24-049979
- form_type: 8-K
- ticker: AVTX
- cik: 0001534120
- company_name: Avalo Therapeutics, Inc.
- filed_at: 2024-12-05T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1534120/000162828024049979/0001628280-24-049979-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1534120/000162828024049979/avtx-20241205.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-24-049979
- JSON: https://secwatch.observer/filing/0001628280-24-049979.json
- Plain text: https://secwatch.observer/filing/0001628280-24-049979.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.